19 employees
Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.
2018
$250M
from 3 investors over 3 rounds
Emalex Biosciences raised $250M on November 3, 2022
Investors: Paragon Biosciences and Valor Equity Partners
Emalex Biosciences raised $15M on June 3, 2020
Investors: Horizon Technology Finance